News Brief Bristol Myers Squibb and Century Therapeutics’ deal for $150M could boost Seattle cell research by Charlotte Schubert on January 10, 2022January 10, 2022 at 9:09 pm Cell therapy company Century Therapeutics will receive a $100 million up front payment and $50 million in equity investment from Bristol Myers Squibb in a deal announced Monday. Under the… Read More